Related Experiment Video
Updated: Jun 6, 2026
13:17
The Mesenteric Lymph Duct Cannulated Rat Model: Application to the Assessment of Intestinal Lymphatic Drug Transport
Published on: March 6, 2015
Using the lymph fistula rat model to study incretin secretion.
Stephanie M Yoder1, Tammy L Kindel, Patrick Tso
1Department of Pathology and Laboratory Medicine, University of Cincinnati, Metabolic Diseases Institute, Cincinnati, Ohio, USA.
Vitamins and Hormones
|November 25, 2010
Summary
Studying incretin hormones like GIP and GLP-1 is crucial for metabolic health. The lymph fistula rat offers a novel method for continuous monitoring of incretin secretion, overcoming limitations of traditional rodent models.
Area of Science:
- Incretin biology and metabolic disorders research.
Background:
- Growing prevalence of type 2 diabetes and metabolic disorders highlights the importance of incretin hormones.
- Glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) play key roles in metabolic regulation.
- Current rodent models face challenges in studying incretin secretion due to low hormone levels and assay sensitivity.
Purpose of the Study:
- To evaluate the lymph fistula rat as a model for studying incretin secretion.
- To address limitations in continuous monitoring of GIP and GLP-1 in small animal models.
Main Methods:
- Utilizing the lymph fistula rat model.
- Leveraging established techniques for studying lipid and lipophilic compound transport in lymph fistula models.
Main Results:
- The lymph fistula model provides a means to overcome challenges associated with low circulating incretin levels.
- This model facilitates more effective continuous monitoring of incretin secretion compared to traditional methods.
Conclusions:
- The lymph fistula rat presents a valuable and effective model for investigating incretin secretion dynamics.
- This approach enhances our understanding of GIP and GLP-1 regulation in metabolic health and disease research.
